Results 191 to 200 of about 44,243 (239)
Some of the next articles are maybe not open access.

The promise of N-acetylcysteine in neuropsychiatry

Trends in Pharmacological Sciences, 2013
N-Acetylcysteine (NAC) targets a diverse array of factors germane to the pathophysiology of multiple neuropsychiatric disorders including glutamatergic transmission, the antioxidant glutathione, neurotrophins, apoptosis, mitochondrial function, and inflammatory pathways.
Michael, Berk   +3 more
openaire   +2 more sources

Pharmacokinetics of N-acetylcysteine in man

European Journal of Clinical Pharmacology, 1986
N-Acetylcysteine was given intravenously and as three fast dissolving and one slow-release formulation, on separate occasions, as a single dose of 600 mg to 10 fasting (5 men and 5 women) healthy volunteers. Blood and urine were sampled for the following 12 h. Renal clearance constituted around 30% of total body clearance, which was 0.21 l/h/kg. Volume
L, Borgström, B, Kågedal, O, Paulsen
openaire   +2 more sources

Hyperthyroidism and N-Acetylcysteine

Journal of the American Medical Directors Association, 2021
Seema, Rao, S, Rao
openaire   +2 more sources

Lipoprotein(a) reduction by N-acetylcysteine

The Lancet, 1991
Lipoprotein(a), a complex of low-density lipoprotein linked by disulphide bridges with apo(a), is associated with atherosclerotic disease when present at very high plasma concentrations. In vitro, N-acetylcysteine (NAC) dissociates this complex. In two patients with high Lp(a) levels NAC lowered plasma Lp(a) from 58 to 20 mg/dl and from 59 to 18 mg/dl:
D, Gavish, J L, Breslow
openaire   +2 more sources

N-acetylcysteine prevents the geldanamycin cytotoxicity by forming geldanamycin–N-acetylcysteine adduct

Chemico-Biological Interactions, 2014
Geldanamycin (GDN) is a benzoquinone ansamycin antibiotic with anti-proliferative activity on tumor cells. GDN cytotoxicity has been attributed to the disruption of heat shock protein 90 (Hsp90) binding and stabilizing client proteins, and by the induction of oxidative stress with concomitant glutathione (GSH) depletion.
Petr, Mlejnek, Petr, Dolezel
openaire   +2 more sources

N-acetylcysteine-cysteine disulfide excretion in the urine following N-acetylcysteine administration

The Journal of Pediatrics, 1969
Summary Three patients taking N-acetylcysteine asa topical pulmonary mucolytic agent have been shown to excrete in urine the mixed disulfide of this compound with cysteine. The disulfide gives a positive cyanide-nitroprusside test and may be easily confused by paper chromatography with beta-mercaptolactate-cysteine disulfide, a substance excreted in ...
V E, Shih, J D, Schulman
openaire   +2 more sources

Clinical Pharmacokinetics of N-Acetylcysteine

Clinical Pharmacokinetics, 1991
N-Acetylcysteine is useful as a mucolytic agent for treatment of chronic bronchitis and other pulmonary diseases complicated by the production of viscous mucus. It is also used as an antidote to paracetamol (acetaminophen) poisoning and found to be effective for the prevention of cardiotoxicity by doxorubicin and haemorrhagic cystitis from ...
openaire   +2 more sources

N-Acetylcysteine in Kidney Disease

2010
Acute kidney injury (AKI) is a frequent complication of contrast administration (contrast-induced nephropathy) and cardiac surgery and is associated with increased short-term and long-term morbidity and mortality. Acute kidney injury is becoming a growing problem in modern cardiovascular medicine, in parallel with the increase in application of ...
G. Marenzi, E. Sisillo, A. Bartorelli
openaire   +2 more sources

N-Acetylcysteine

Revue de l'infirmiere, 2010
Jean-Michel Scherrmann   +199 more
openaire   +3 more sources

N-Acetylcysteine in Sepsis

1994
Sepsis, septic shock and multiple organ dysfunction syndrome are characterized by progressive inadequate tissue perfusion and maldistribution of blood flow [1]. Endothelium-derived relaxing factor is considered to be important in maintaining nutrive blood flow [2].
C. Spies, K. Reinhart
openaire   +1 more source

Home - About - Disclaimer - Privacy